Attenuation of p53 expression and Bax down-regulation during phorbol ester mediated inhibition of apoptosis

British Journal of Pharmacology

Volumn 121, Issue 4, 1997, Pages 625-634

  Meßmer, Udo K ^a,b   Brüne, Bernhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Apoptosis; Bax down regulation; Nitric oxide; p53; Phorbol ester

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; BISINOYLMALEIMIDE; DACTINOMYCIN; DNA FRAGMENT; ETOPOSIDE; MALEIMIDE DERIVATIVE; MEZEREIN; MITOMYCIN C; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN BAX; PROTEIN KINASE C INHIBITOR; PROTEIN P53; S NITROSOGLUTATHIONE; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; DITERPENES; DOWN-REGULATION; GENES, P53; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TERPENES; TETRADECANOYLPHORBOL ACETATE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0030962230     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701156     Document Type: Article

References (56)

1. ALBINA, J.E, CUI, S., MATEO, R.B. & REICHNER, J.S. (1993). Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol., 150, 5080-5085.
2. BARAK, Y., JUVEN, T., HAFFNER, R. & OREN, M. (1993). mdm-2 expression is induced by wild type p53 activity. EMBO J., 12, 461-468.
3. BARINAGA, M. (1996). Apoptosis - Life-death balance within the cell. Science, 274, 724.
4. BAUDIER, J., DELPHIN, C., GRUNWALD, D., KHOCHBIN, S. & LAWRENCE, J.J. (1992). Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl. Acad. Sci. U.S.A., 89, 11627-11631.
5. BLANCO, F.J., OCHS, R.L., SCHWARZ, H. & LOTZ, M. (1995). Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol., 146, 75-85.
6. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. BURTON, K. (1956). A study of the conditions and mechanism of the diphenylamine reaction for the estimation of deoxyribonucleic acid. Biochem. J., 62, 315-323.
8. COPPOLA, J., BRYANT, S., KODA, T., CONWAY D. & BARBACID, M. (1991). Mechanism of activation of the vav protooncogene. Cell Growth Differ., 2, 95-105.
9. DE-ROJAS-WALKER, T., TAMIR, S., JI, H., WISHNOK, J.S. & TANNENBAUM, S.R. (1995). Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem. Res. Toxicol., 8, 473-477.
10. DING, A.H., NATHAN, C.F. & STUEHR, D.J. (1990). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol., 141, 2407-2412.
11. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, E., KINZLER, K.W. & VOGELSTEIN, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
12. HAIMOVITZ-FRIEDMAN, A., BALABAN, N., McLOUGHLIN, M., EHLEITER, D., MICHAELI, J., VLODAVSKY, I. & FUKS, Z. (1994a). Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res., 54, 2591-2597.
13. HAIMOVITZ-FRIEDMAN, A., KAN, C.C., EHLEITER, D., PERSAUD, R.S., MCLOUGHLIN M., FUKS, Z. & KOLESNIK, R.N. (1994b). Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180, 525-535.
14. HALDAR, S., JENA, N. & CROCE, C.M. (1995). Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. U.S.A., 92, 4507-4511.
15. 2-Chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternative splicing of the human n-chimerin gene, is alternatively expressed in brain regions and testes. Mol. Cell Biol., 13, 4986-4998.
16. HARPER, J.W., ADAMI, G.R., WEI, N., KEYOMARSI, K. & ELLEDGE, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
17. HART, T.W. (1985). Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione. Tetrahedron Lett., 26, 2013-2016.
18. IGNARRO, L.J. (1990). Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol., 30, 535-560.
19. JARVIS, W.D., FORNARI, F.A., JR., BROWNING, J.L., GEWIRTZ, D.A., KOLESNICK, R.N. & GRANT, S. (1994a). Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem., 269, 31685-31692.
20. JARVIS, W.D., KOLESNICK, R.N., FORNARI, F.A., TRAYLOR, R.S., GERWITZ, D.A. & GRANT, S. (1994b). Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. U.S.A., 91, 73-77.
21. KANETO, H., FUJII, J., SEO, H.G., SUZUKI, K., MATSUOKA, T., NAKAMURA, M., TATSUMI, H., YAMASAKI, Y., KAMADA, T. & TANIGUCHI, N. (1995). Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes, 44, 733-738.
22. KASTAN, M.B., ZHAN, Q., EL-DEIRY, W.S., CARRIER, F., JACKS, T., WALSH, W.V., PLUNKETT, B.S., VOGELSTEIN, B. & FORNANCE, A.J., JR. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
23. LIEBERMANN, D.A., HOFFMAN, B. & STEINMAN, R.A. (1995). Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene, 11, 199-210.
24. LIN, W.-C. & DESIDERIO, S. (1993). Regulation of V(D)J recombination activator protein RAG-2 by phosphorylalion. Science, 260, 953-959.
25. LUCAS, M. & SÁNCHEZ-MARGALET, V. (1995). Protein kinase C involvement in apoptosis. Gen. Pharmacol., 26, 881-887.
26. MAGNELLI, L., CINELLI, M. & CHIARUGI, V. (1995). Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect ts-p53/K563 from apoptosis. Biochem. Biophys. Res. Commun. 215, 641-645.
27. MARTINY-BARON, G., KAZANIETZ, M.G., MISCHAK, H., BLUMBERG, P.M., KOCHS, G., HUG, H., MARMÉ, D. & SCHÄCHTELE, C. (1993). Selective inhibition of protein kinase C isoenzymes by the indolocarbazole Gö 6976. J. Biol. Chem., 268, 9194-9197.
28. MAY, W.S., TYLER, P.G., ARMSTRONG, D.K. & DAVIDSON, N.E. (1993). Role for serine phosphorylation of Bcl-2 in an antiapoptotic signaling pathway triggered by IL-3, EPO and bryoslatin. Blood, 82, (Suppl. 1), 1738.
29. McCONKEY, D.J., HARTZELL, P., JONDAL, M. & ORRENIUS, S. (1989). Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem., 264, 13399-13402.
30. MEEK, D.W. (1994). Post-transitional modification of p53. Sem. Cancer Biol., 5, 203-210.
31. MERCER, W.E., SHIELDS, M.T., LIN, D., APELLA, E. & ULLRICH, S.J. (1991). Growth suppression induced by wild type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen. Proc. Natl. Acad. Sci. U.S.A., 88, 1958-1962.
32. MEßMER, U.K., ANKARKRONA, M., NICOTERA, P. & BRÜNE, B. (1994). p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 355, 23-26.
33. + content, and p53 accumulation. Arch. Biochem. Biophys., 327, 1-10.
34. MEßMER, U.K. & BRÜNE, B. (1996b). Nitric oxide-induced apoptosis: p53-dependent and p53-independent pathways. Biochem. J., 319, 299-305.
35. MEßMER, U.K., LAPETINA, E.G. & BRÜNE, B. (1995). Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol., 47, 757-765.
36. MEßMER, U.K., REED, J.C. & BRÜNE, B. (1996). Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem., 271, 20192-20197.
37. MILNER, J. (1994). Forms and functions of p53. Sem. Cancer Biol., 5, 211-219.
38. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKA, M., WANG, H.G., LIN, H.K., LIEBERMANN, D.A., HOFFMAN, B. & REED, J.C. (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
39. MIYASHITA, T. & REED, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
40. MOHR, S., STAMLER, J.S. & BRÜNE, B. (1996). Posttranslational modification of glyceraldehyde-3-phosphale dehydrogenase by S-nitrosylation and subsequent NADH attachment. J. Biol. Chem., 271, 4209-4214.
41. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
42. NATHAN, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
43. NGUYEN, T., BRUNSON, D., CRESPI, C.L., PENMAN, B.W., WISHNOK, J.S. & TANNENBAUM, S.R. (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. U.S.A., 89, 3030-3034.
44. OBEID, L.M., LINARDIC, C.M., KAROLAK, L.A. & HANNUN, Y.A. (1993). Programmed cell death induced by ceramide. Science, 259, 1769-1771.
45. OLTAVI, Z.N., MILLIMAN, C.L. & KORSMEYER, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell, 74, 609-619.
46. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
47. PRICE, B.D. & CALDERWOOD, S.K. (1993). Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene, 8, 3055-3062.
48. SANCHEZ, V., LUCAS, M., SANZ, A. & GOBERNA, R. (1992). Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes. Biosci. Report. 12, 199-206.
49. SARIH, M., SOUVANNAVONG, V. & ADAM, A. (1993). Nitric oxide induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun., 191, 503-508.
50. SELTER, H. & MONTENARH, M. (1994). The emerging picture of p53. Int. J. Biochem., 26, 145-154.
51. SMITH, M.L., CHEN, I.-T., ZHAN, Q., BAE, I., CHEN, C.-Y., GILMER, T.M., KASTAN, M.B., O'CONNOR, P.M. & FORNANCE, A.J., JR. (1994). Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 266, 1376-1380.
52. TAKENADA, I., MORIN, F., SEIZINGER, B.R. & KLEY, N. (1995). Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphateases. J. Biol. Chem., 270, 5405-5411.
53. TOULLEC, D., PIANETTI, P., COSTE, H., BELLEVERGUE, P., GRAND-PERRET, T., AJAKANE, M., BAUDET, A., BOISSIN, P., BOURSIER, E., LORIOLLE, F., DUHAMEL, L., CHARON, D. & KIRILOVSKY, J. (1991). The bisindoylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem., 266, 15771-15781.
54. WIGLER, M., PELLICER, A., SILVERSTEIN, S., AXEL, R., URLAUB, G. & CHASIN, L. (1979). DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. U.S.A., 76, 1373-1376.
55. WINK, D.A., KASPRZAK, K.S., MARAGOS, C.M., ELESPURU, R.K., MISRA, M., DUNAMS, T.M., CEBULA, T.A., KOCH, W.H., ANDREWS, A.W., ALLEN, J.S. & KEEFER, L.K. (1991). DNA-deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 254, 1001-1003.
56. WRIGHT, S.C., ZHONG, J. & LARRICK, J.W. (1994). Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8, 654-660.